Stay updated with breaking news from Agrx. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Agile Therapeutics, Inc. (NASDAQ:AGRX – Get Rating) shares passed above its 50-day moving average during trading on Friday . The stock has a 50-day moving average of $0.22 and traded as high as $0.30. Agile Therapeutics shares last traded at $0.29, with a volume of 576,188 shares. Wall Street Analyst Weigh In Separately, StockNews.com initiated […]
Agile Therapeutics, Inc. (NASDAQ:AGRX – Get Rating) was the target of a significant growth in short interest in May. As of May 31st, there was short interest totalling 502,600 shares, a growth of 126.7% from the May 15th total of 221,700 shares. Approximately 11.4% of the shares of the stock are sold short. Based on […]
Agile Therapeutics, Inc. (NASDAQ:AGRX – Get Rating) was the target of a large drop in short interest during the month of May. As of May 15th, there was short interest totalling 221,700 shares, a drop of 22.7% from the April 30th total of 286,900 shares. Currently, 5.0% of the company’s shares are short sold. Based […]
StockNews.com assumed coverage on shares of Agile Therapeutics (NASDAQ:AGRX – Get Rating) in a research report issued to clients and investors on Thursday. The brokerage set a “sell” rating on the specialty pharmaceutical company’s stock. Several other research analysts have also recently issued reports on the stock. Zacks Investment Research upgraded shares of Agile Therapeutics […]
Agile Therapeutics, Inc. (NASDAQ:AGRX – Get Rating) has been assigned an average recommendation of “Hold” from the six ratings firms that are presently covering the stock, MarketBeat reports. Two research analysts have rated the stock with a sell rating and four have assigned a buy rating to the company. The average 1-year target price among […]